NCT04559165Unknown不适用
Efficacy and Safety of Sericin and Chitosan Cream for Preventing and Limiting the Progressive of Pressure Sore
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- Pressure ulcer scale for healing
研究概览
简要总结
To evaluate efficacy and safety of sericin and chitosan cream for preventing and limiting the progressive of pressure sore in 20 patients
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age more than 18 years old
- •2-digit Stirling Pressure Sore Severity Scale less than or equal to 2.4
- •No chitosan, sericin, and dimethicone allergy
- •Without skin diseases
- •Without Autoimmune diseases
- •Willingness to participate
排除标准
- •Have uncontrolled diseases
- •Have complication or adverse effects during the time of participation
- •Cannot follow protocol
- •Pregnancy or lactation
- •Participate in other study
结局指标
主要结局
Pressure ulcer scale for healing
时间窗: 21 days
Score 0 to 17, higher scores mean a worse outcome
次要结局
- Adverse events(21 days)
- Erythema index(21 days)
- Melanin index(21 days)
- Transepidermal water loss(21 days)
- Moisture index(21 days)
研究者
Pornanong Aramwit, Pharm.D., Ph.D
Professor
Chulalongkorn University
研究点 (2)
Loading locations...
相似试验
尚未招募
不适用
Safety of Cream Containing Sericin and Turmeric in Healthy VolunteersSafety IssuesNCT05869357Chulalongkorn University106
尚未招募
不适用
Cream Containing Sericin and Turmeric in Psoriasis PatientsPsoriasisNCT06482398Chulalongkorn University30
Unknown
不适用
Efficacy and Safety of Silicone Cream Containing Allium Cepa ExtractCicatrixNCT04233320Chulalongkorn University22
终止
4 期
The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry EyeDry EyeNCT00553735Massachusetts Eye and Ear Infirmary8
进行中（未招募）
不适用
Mepiform in Simultaneous Bilateral TKAScar PreventionNCT06312527Thammasat University Hospital30